High dose vitamin D may not affect COVID-19 severity or number of hospital visits, however, it may slightly reduce the development of long COVID symptoms. The corresponding study was published in The ...

High-dose Vitamin D doesn't reduce acute COVID severity but shows a promising signal for reducing Long COVID and brain fog.

Since the pandemic’s early days, many people have looked to vitamin D as a possible shield against the worst effects of COVID ...

Vitamins and dietary supplements are often viewed as harmless additions to daily health routines, but recent scientific evidence shows that certain high-dose supplements may cause more harm than good.

In a large, randomized trial, researchers at Mass General Brigham have found that high-dose vitamin D3 did not reduce COVID-19 infection severity, but may impact long COVID outcomes.

A major clinical trial has delivered an unexpected twist in the search for ways to fight COVID-19 and its lingering effects. Researchers at Mass General Brigham found that taking high doses of vitamin ...

In a new study, heart attack survivors who received a high, personalized dose of daily vitamin D had a 52 percent lower risk of a repeat heart attack. The results suggest specific vitamin D dosing, ...

Two doses of vitamin D were investigated for their potential to have a positive impact on systolic and diastolic blood pressures when administered in conjunction with calcium. Outcomes in a new ...

High-dose oral cholecalciferol (vitamin D3) supplementation significantly reduced disease activity in patients with clinically isolated syndrome (CIS) suggestive of multiple sclerosis (MS) in the ...

NEW YORK (Reuters Health) - A new analysis of nearly a dozen studies testing vitamin D in older individuals has concluded that it takes a daily dose of at least 800 international units (IU) to ...

Vitamin D supplements are linked to many health benefits, including decreasing the chance of heart disease, supporting immune function, and aiding weight loss. New research suggests that calcium and ...

BARCELONA, Spain — The addition of high-dose vitamin D supplementation to standard chemotherapy plus bevacizumab did not result in a significant progression-free survival benefit in patients with ...